The Boehringer Ingelheim booth is seen at the fourth China International Import Expo in Shanghai in November. German multinational pharmaceutical company Boehringer Ingelheim has maintained strong growth in the Chinese market as all three major business units achieved outstanding performance last year to propel the company's overall rapid development in China, according to the company's annual result report for 2021 …
